The Saudi Thrombosis and Familial Thrombophilia Registry: Design, rational, and preliminary results

Saudi Medical Journal

Volumn 30, Issue 10, 2009, Pages 1286-1290

  Saour, Jalal N ^a   Shoukri, Mohammed M ^a   Mammo, Layla A ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN;

ADULT; ARTICLE; AWARENESS; CONTROLLED STUDY; DISEASE REGISTRY; DNA EXTRACTION; FAMILIAL DISEASE; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC RISK; HAPLOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; POPULATION GENETICS; PREVALENCE; SAUDI ARABIA; THROMBOPHILIA; THROMBOSIS;

DNA; FACTOR V; HOMOZYGOTE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTHROMBIN; REFERENCE VALUES; REGISTRIES; SAUDI ARABIA; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 70449640744     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Ettema HB, Kollen BJ, Verheyen CC, Büller HR. Prevention of venous thromboembolism in patients with immobilization of the lower extremities: a meta-analysis of randomized controlled trials. J Thromb Haemost 2008; 6: 1093-1098.
2. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 2008; 133 (6 Suppl): 381S-453S. (Pubitemid 351894916)
3. Heit JA. The epidemiology of venous thromboembolism in the community: implications for prevention and management. J Thromb Thrombolysis 2006; 21: 23-29. (Pubitemid 43231124)
4. Rosendaal FR. Venous thrombosis: the role of genes, environment, and behavior. Hematology Am Soc Hematol Educ Program 2005; 1: 1-12.
5. Zoller B, Garcia De Fruitos P, Hillarp A, Dahlback B. Thrombophilia as a Multigenic Disease. Haematologica 1999; 84: 59-70.
6. van der Meer FJ, Koster T, Vandenbroucke JP, Briët E, Rosendaal FR. The Leiden Thrombophilia Study (LETS). Thromb Haemost 1997; 78: 631-635.
7. Folsom AR, Cushman M, Heckbert SR, Rosamond WD, Aleksic N. Prospective study of fibrinolytic markers and venous thromboembolism. J Clin Epidemiol 2003; 56: 598-603. (Pubitemid 36842919)
8. Martinelli I, Mannucci PM, De Stefano V, Taioli E, Rossi V, Crosti F, et al. Differential risks of thrombosis for four coagulation defects associated with inherited thrombophilia. Blood 1998; 92: 2353-2358. (Pubitemid 28452977)
9. Ridker PM, Hennekens CH, Selhub J, Miletich JP, Malinow MR, Stampfer MJ. Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism. Circulation 1997; 95: 1777-1782 (Pubitemid 27164393)
10. Rees DC, Chapman NH, Webster MT, Guerreiro JF, Rochette J, Clegg JB. Born to clot: the European burden. Br J Haematol 1999; 105: 564-566.
11. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-113.
12. de Visser MC, Guasch JF, Kamphuisen PW, Vos HL, Rosendaal FR, Bertina RM. The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis. Thromb Haemost 2000; 83: 577-582.
13. Castaman G, Faioni EM, Tosetto A, Bernardi F. The factor V HR2 haplotype and the risk of venous thrombosis: a meta-analysis. Haematologica 2003; 88: 1182-1189. (Pubitemid 37362552)
14. Francis CW. Plasminogen activator inhibitor-1 levels and polymorphisms. Arch Pathol Lab Med 2002; 126: 1401-1404.
15. Fowkes FJ, Price JF, Fowkes FG. Incidence of diagnosed deep vein thrombosis in the general population: systematic review. Eur J Vasc Endovasc Surg 2003; 25: 1-5.
16. Bagot CN, Arya R. Virchow and his triad: a question of attribution. Br J Haematol 2008; 143: 180-190.
17. Cooper DN. The molecular genetics of familial venous thrombosis. Baillieres Clin Haematol 1994; 7: 637-674. (Pubitemid 24296883)
18. Bertina RM. Genetic Approach to thrombophilia. Thromb Haemost 2001; 86: 92.
19. van Vlijmen EF, Brouwer JL, Veeger NJ, Eskes TK, de Graeff PA, van der Meer J. Oral contraceptives and the absolute risk of venous thromboembolism in women with single or multiple thrombophilic defects: results from a retrospective family cohort study. Arch Intern Med 2007; 167: 282-289.
20. Mateo J, Oliver A, Borrell M, Sala N, Fontcuberta J. Laboratory evaluation and clinical characteristics of 2,132 consecutive unselected patients with venous thromboembolism--results of the Spanish Multicentric Study on Thrombophilia (EMET-Study). Thromb Haemost 1997; 77: 444-451. (Pubitemid 27121006)
21. Heijboer H, Brandjes DP, Büller HR, Sturk A, ten Cate JW. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. N Engl J Med 1990; 323: 1512-1516.
22. Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999; 340: 9-13. (Pubitemid 29024678)
23. Saour J, Mammo L. Prevalence of FVL, Prothrombin G20210A and MTHFR C677T in Normal Saudi Arabian: A preliminary report on the Saudi Thrombosis and Familial Thrombophilia Registry. J Thromb Haemost 2005; 3 (Suppl 1): 1863.
24. Mammo L, Sheereen A, Saour T, Shoukri M, Saour J. Incidence of five prothrombotic gene polymorphisms in healthy Saudi Arabians. J Thromb Heamost 2007; 5: 882. (Pubitemid 46563596)
25. SaourJ, Sheereen A, Mammo L. The 4g/5g insertion/deletion polymorphism of the plasminogen activator inhibitor-1 gene is associated with venous thrombosis. J Thromb Haemost 2007; 5 (Suppl 2): p. S359.